O
The startup has developed a drug discovery platform that integrates multi-omics data analysis, cell engineering, and animal model testing specifically for reproductive health conditions. This platform enables clients to accelerate the development of novel therapeutics and enhance the validation process for new treatments.
London, United KingdomFounded 2024
Updated 3 months ago
Funding
$560K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup has developed a drug discovery platform that integrates multi-omics data analysis, cell engineering, and animal model testing specifically for reproductive health conditions. This platform enables clients to accelerate the development of novel therapeutics and enhance the validation process for new treatments.